Table 2.

The Number and Incidence Rate of Hepatocellular Carcinoma and Its Underlying Etiologies in China in 2021.

	Overall		Hepatocellular Carcinoma Due to Hepatitis B		Hepatocellular Carcinoma Due to Hepatitis C		Hepatocellular Carcinoma Due to Alcohol Use		Hepatocellular Carcinoma Due to NASH		Hepatocellular Carcinoma Due to Other Cause
	Incidence Cases (95% UI)	ASIR Per 100,000 (95% UI)	Incidence Cases (95% UI)	ASIR Per 100,000 (95% UI)	Incidence Cases (95% UI)	ASIR Per 100,000 (95% UI)	Incidence Cases (95% UI)	ASIR Per 100,000 (95% UI)	Incidence Cases (95% UI)	ASIR Per 100,000 (95% UI)	Incidence Cases (95% UI)	ASIR Per 100,000 (95% UI)
Both	196,636.59 (158,273.06, 243,557.68)	9.52 (7.72, 11.78)	118,664.63 (92,279.81, 153,555.83)	5.73 (4.48, 7.38)	36,427.20 (28,403.62, 44,839.52)	1.78 (1.41, 2.18)	20,463.70 (15,239.13, 27,295.73)	0.94 (0.71, 1.25)	11,292.71 (8663.08, 14,313.98)	0.54 (0.42, 0.68)	9235.20 (7034.47, 11,874.65)	0.45 (0.34, 0.57)
Femlae	52,848.43 (41,045.47, 67,025.70)	4.89 (3.82, 6.18)	16,822.07 (12,386.23, 22,196.51)	1.56 (1.16, 2.07)	19,924.28 (15,197.93, 25,487.43)	1.81 (1.39, 2.31)	6579.11 (4820.34, 8696.52)	0.58 (0.43, 0.77)	5133.09 (3874.44, 6818.26)	0.47 (0.35, 0.62)	4153.79 (3057.60, 5491.58)	0.39 (0.29, 0.51)
Male	143,788.16 (108,926.76, 193,830.93)	14.34 (10.93, 19.18)	101,842.56 (76,298.12, 137,860.95)	10.04 (7.60, 13.49)	16,502.92 (12,102.56, 22,376.81)	1.75 (1.29, 2.33)	13,884.60 (9568.75, 19,670.88)	1.33 (0.93, 1.85)	6159.62 (4347.41, 8447.05)	0.63 (0.45, 0.84)	5081.41 (3624.03, ) 7319.05	0.51 (0.36, 0.72)

UI: uncertainty interval; NASH: Non-alcoholic steatohepatitis; ASIR: age-standardized incidence rate.